Results 221 to 230 of about 347,264 (390)

Evaluation of Erythropoietin and Erythropoietin Receptor Levels in Children with Autistic Spectrum Disorder: Cross-sectional Study. [PDF]

Clin Psychopharmacol Neurosci
Oner E, Kurutas EB, Altun H.
europepmc   +1 more source

Case Report: Vitamin C combined with multiple micronutrient deficiencies is associated with pulmonary arterial hypertension in children with autistic spectrum disorder. [PDF]

Front Nutr, 2022
Sakamornchai W, Dumrongwongsiri O, Siwarom S.   +2 more
europepmc   +1 more source

Lesions Associated With Autism Symptoms Map to a Cerebellar Brain Network in Tuberous Sclerosis Complex

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Objective Autism spectrum disorder (ASD) affects 1 in 36 individuals in the United States and is characterized by impaired social communication and restrictive/repetitive behaviors. Individuals with tuberous sclerosis complex (TSC) have a high incidence of ASD (40%) and exhibit congenital brain lesions (tubers), offering a unique lesion‐based ...
Wendy Xiao Herman, Gillian N. Miller, Mustafa Sahin, Jurriaan M. Peters, Simon K. Warfield, Darcy A. Krueger, E. Martina Bebin, Hope Northrup, Joyce Y. Wu, Michael D. Fox, Alexander L. Cohen   +10 more
wiley   +1 more source

Association of physical activity and sleep habits during pregnancy with autistic spectrum disorder in 3-year-old infants. [PDF]

Commun Med (Lond), 2022
Nakahara K, Michikawa T, Morokuma S, Hamada N, Ogawa M, Kato K, Sanefuji M, Shibata E, Tsuji M, Shimono M, Kawamoto T, Ohga S, Kusuhara K, Japan Environment and Children’s Study Group.   +13 more
europepmc   +1 more source

Establishing a Translational Science for Autistic Spectrum Disorders for Children and Their Families: Optimizing Function, Participation, and Well-Being [PDF]

, 2009
Michael E. Msall
openalex   +1 more source

Benefits of active control of study in autistic children [PDF]

, 2019
De Simone, C., Fantasia, V., Markant, D., Perri, N., Ruggeri, A., Valeri, G.   +5 more
core  

Cannabidiol in autism: Clinical pharmacology priorities for trial design

British Journal of Clinical Pharmacology, EarlyView.
Gislei Frota Aragão, Carla Barbosa Brandão, José Evaldo Leandro Júnior   +2 more
wiley   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Children with autistic spectrum disorder can imagine actions- what can this reveal about the Broken Mirror Hypothesis? [PDF]

Front Neurol
Galli J, Dusi L, Garofalo G, Brizzi A, Gritti M, Polo F, Fazzi E, Buccino G.   +7 more
europepmc   +1 more source

A Case Series of Intermittent Theta Burst Stimulation Treatment for Depressive Symptoms in Individuals with Autistic Spectrum Disorder: Real World TMS Study in the Tokyo Metropolitan Area. [PDF]

J Pers Med, 2023
Noda Y, Fujii K, Mimura Y, Taniguchi K, Nakajima S, Kitahata R.   +5 more
europepmc   +1 more source